Takeda Assembles Team to Evaluate Zika Vaccine Possibilities

A lab technician analyzes blood samples of pregnant women in Guatemala, Pharmaceutical companies are beginning work toward a vaccine to combat Zika.

Photographer: Johan Ordonez/AFP via Getty Images

Takeda Pharmaceutical Co., Asia’s largest drugmaker, has assembled an internal team to look into how it might contribute to vaccine efforts to combat the Zika virus, the mosquito-borne pathogen that is currently spreading through the Americas.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.